Reply to D.M. Green-Reference-Cited by-同舟云学术

Reply to D.M. Green

Published:2018-11-01 Issue:31 Volume:36 Page:3179-3181
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dix David B.¹,Seibel Nita L.¹,Chi Yueh-Yun¹,Khanna Geetika¹,Mullen Elizabeth A.¹,Geller James I.¹,Kalapurakal John A.¹,Ehrlich Peter F.¹,Malogolowkin Marcio H.¹,Fernandez Conrad V.¹,Dome Jeffrey S.¹

Affiliation:

1. David B. Dix, British Columbia Children’s Hospital, Vancouver, BC, Canada; Nita L. Seibel, National Cancer Institute, Bethesda, MD; Yueh-Yun Chi, University of Florida, Gainesville, FL; Geetika Khanna, Washington University School of Medicine, St Louis, MO; Elizabeth A. Mullen, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA; James I. Geller, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; John A. Kalapurakal, Lurie Comprehensive Cancer Centre of Northwestern...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.18.00659

Reference10 articles.

1. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases

2. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children’s Oncology Group AREN0533 Study

3. Treatment of Pulmonary Metastases in Children With Stage IV Nephroblastoma With Risk-Based Use of Pulmonary Radiotherapy

4. The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors’ Reply to the Letter to the Editor by Daniel M. Green;Journal of the National Comprehensive Cancer Network;2022-03

2. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor;Journal of Clinical Oncology;2020-03-01